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Introduction 
Honey is a natural product with very complex chemical 
compositioncontaining  at  least  181  different 
substances.
1It  is  composed  primarily  of  fructose  and 
glucose  but  also  contains  fructo-oligosaccharides,
1 
many  amino  acids,  vitamins,  minerals  and  enzymes.
2 
The composition of honey varies according to the plant 
origin  on  which  the  bee  feeds.  However,  all  honeys 
almost  contain  flavonoids  (such  as  apigenin, 
pinocembrin, kaempferol,  quercetin, galangin,  chrysin 
and hesperetin), phenolic acids (such as ellagic, caffeic, 
p-coumaric  and  ferulic  acids),  ascorbic  acid, 
tocopherols,  catalase  (CAT),  superoxide  dismutase 
(SOD),  reduced  glutathione  (GSH),  Millard  reaction 
products and peptides, most of them work together to 
provide a synergistic antioxidant effect.
3-7 
Honey has had a valued place in traditional medicine 
for centuries.
8,9 However, it has a limited use in modern 
medicine due to lack of scientific support.
10 For a long 
time, it has been observed that honey can be used to 
overcome  liver,  cardiovascular  and  gastrointestinal 
problems.
11  Ancient  Egyptians,  Assyrians,  Chinese, 
Greeks and Romans employed honey for wounds and 
diseases of the intestine.
12 From the past few decades, 
honey  was  subjected  to  laboratory  and  clinical 
investigations  by  several  research  groups.  The  most 
remarkable  discovery  was  antibacterial  activity  of 
honey that has been mentioned in numerous studies.
13,14 
Natural  honey  exhibits  bactericidal  activity  against 
many  organisms  including  Salmonella,  Shigella,  E. 
coli,
3,15  some  methicillin-resistant  Staphylococcus 
aureus strains
14 and Helicobacter pylori.
9 Avicenna, the 
great Iranian scientist and physician, almost 1000 years 
ago, had recommended honey as one of best remedies 
in the treatment of tuberculosis.
16 An antifungal action 
has also been observed for some yeasts and species of 
Aspergillus and Penicillium, as well as all the common 
dermatophytes.
17  Effectiveness  of  honey  to  treat 
severely  infected  cutaneous  wounds  also  was 
A R T I C L E  I N F O                             A B S T R A C T 
Article Type: 
Research Article 
Article History: 
Received: 5 June 2012 
Accepted: 20 June 2012 
ePublished: 25 June 2012 
Keywords: 
Natural honey 
Global ischemia 
Arrhythmia 
Infarction 
Preischemic  administration 
Isolated rat heart 
Purpose: In the present study, effects of preischemic administration of natural honey on 
cardiac arrhythmias and myocardial infarction size during zero flow global ischemia 
were investigated in isolated rat heart. Methods:The isolated hearts were subjected to 
30 min zero flow global ischemia followed by 120 min reperfusion then perfused by a 
modified drug free Krebs-Henseleit solution throughout the experiment (control) or the 
solution containing 0.25, 0.5, 1 and 2% of natural honey for 15 min before induction of 
global ischemia  (treated  groups),  respectively.  Cardiac  arrhythmias  were  determined 
based on the Lambeth conventions and the infarct size was measured by computerized 
planimetry. Results: Myocardial infarction size was 55.8±7.8% in the control group, 
while preischemic perfusion of honey (0.25, 0.5, 1  and 2%) reduced it to 39.3±11, 
30.6±5.5 (P<0.01), 17.9±5.6 (P<0.001) and 8.7±1.1% (P<0.001), respectively. A direct 
linear  correlation  between  honey  concentrations  and  infarction  size  reduction  was 
observed  (R
2=0.9948). In addition, total number of ventric ular ectopic beats were 
significantly decreased by all used concentrations of honey (P<0.05) during reperfusion 
time. Honey (0.25, 0.5 and 1 %) also lowered incidence of irreversible ventricular 
fibrillation (P<0.05). Moreover, number and duration of ventr icular tachycardia were 
reduced in all honey treated groups. Conclusion: Preischemic administration of natural 
honey  before  zero  flow  global  ischemia  can  protect  isolated  rat  heart  against 
ischemia/reperfusion injuries as reduction of infarction size and arrhythmias. Maybe, 
antioxidant  and  free  radical  scavenging  activities  of  honey,  reduction  of  necrotized 
tissue and providing energy sources may involve in these cardioprotective effects of 
honey.  
166| 
Najafi et al. 
 
Advanced Pharmaceutical Bulletin,2012, 2(2), 165-171  Copyright © 2012 by Tabriz University of Medical Sciences 
confirmed  in  recent  clinical  case  studies.
18  In  an 
inflammatory model of colitis, honey was as effective 
as  prednisolone  treatment.
19  Research  has  also 
indicated  that  honey  may  possess  anti-inflammatory 
activity  and  stimulate  immune  responses  within  a 
wound.
20,21  Al-Waili  and  Boni  (2003)  demonstrated 
anti-inflammatory  effects  of  honey  in  humans  after 
ingestion  of  70  g  of  honey.  They  showed  that 
consumption  of  honey  lowered  mean  plasma 
concentrations  of  thromboxane  B2,  and  prostaglandin 
E2  and  F2α.
22  Honey,  interestingly,  has  shown  to 
prevent  reactive  oxygen  species  (ROS)-induced  low 
density  lipoprotein  (LDL)  oxidation  in  some  in  vitro 
studies,  thus  exhibiting  beneficial  cardiovascular 
protection.
23,24 Honey has also antineoplastic activity in 
an  experimental  bladder  cancer.
25  Other  medicinal 
properties of honey and other hive products have been 
described  for  a  variety  of  medicinal  and  nutritional 
purposes by other studies.
26-28 
To  date,  majority  of  studies  have  focused  on  the 
potential  health  benefits  of  honey  for  human,  but  its 
efficacy on cardiovascular disease such as arrhythmia 
and  myocardial  infarction  is  not  completely 
understood.  Previously,  we  showed  cardioprotective 
effects of chronic oral administration of natural honey 
(for 45 days) against ischemia/reperfusion (I/R) injuries 
in  rat.
29  In  the  present  study,  effects  of  preischemic 
administration of natural honey on cardiac arrhythmias 
and myocardial infarction size during zero flow global 
ischemia were investigated in isolated rat heart.  
 
Materials and Methods 
The  following  chemicals  were  purchased:  Honey 
(Oskou,  East  Azerbaijan,  Iran),  Triphenyltetrazolium 
chloride  (TTC)  (Sigma),  Formalin,  NaCl,  NaHCO3, 
KCl,  KH2PO4,  MgSO4,  CaCl2,  D-glucose  (Merck 
Company),  Sodium  pentobarbital  (Kela  Company, 
Belgium) and Heparin (Daru-pakhsh Company, Iran). 
 
Animals and surgical procedure 
Male Wistar rats weighing 270-320 g were divided into 
five  groups  randomly  as  a  control  and  four  treated 
groups  (n=10-14  in  each  group).  The  rats  were 
pretreated with intraperitoneal (i.p.) injection of 300 IU 
heparin  then  anaesthetized  by  sodium  pentobarbital 
(50-60  mg/kg,  i.p.).  The  hearts  were  excised  rapidly 
and  mounted  on  a  non-recirculating  langendorff 
apparatus  under  constant  pressure  of  100  mmHg  at 
37°C  and  perfused  with  modified  Krebs-Henseleit 
(K/H)  solution  that  previously  equilibrated  with  95% 
O2-5% CO2. A latex fluid filled balloon was inserted 
into the left ventricle and inflated to give a preload of 
8-10 mmHg.
30 All the hearts were subjected to 20 min 
stabilization,  15  min  preischemic  time,  30  min  zero 
flow global ischemia followed by 120 min reperfusion. 
In  the  control  group,  the  hearts  were  perfused  by 
normal  drug  free  K/H  solution  throughout  the 
experiments,  while  in  the  treated  groups,  they  were 
perfused with K/H solution containing 0.25, 0.5, 1 and 
2% of natural honey during 15 min preischemic period 
before  induction  of  global  ischemia.  Similar  to  the 
control group, drug free K/H solution were perfused to 
treated  isolated  hearts  during  stabilization  and 
reperfusion.  At  stabilization  time,  any  animal  with 
experienced  persistent  arrhythmias  was  discarded.
31-33 
An  epicardial  ECG  was  recorded  continuously  by  a 
physiograph  during  the  experiment.  Based  on  the 
Lambeth  conventions,
34  the  ECGs  were  analyzed  to 
determine  the  number  of  single  ectopic  beats,  salvos 
(couplets and triplets), ventricular tachycardia (VT), the 
total  number  of  ventricular  ectopic  beats  (VEBs), 
incidence and duration of VT and reversible ventricular 
fibrillation  (Rev  VF)  and  incidence  of  irreversible 
ventricular  fibrillation  (Irrev  VF)  during  the  first  30 
min  of  reperfusion  time.
35 The  experiments  reported 
were carried out in accordance with the Guide for the 
Care  and  Use  of  Laboratory  Animals  (National 
Institutes  of  Health  Publication  No  85-23,  revised 
1985). 
 
Measurement of myocardial infarction size 
To determine the infarction size, at the end of 120 min 
reperfusion,  the  hearts  were  frozen,  and  then  sliced 
transversely in a plane perpendicular to the apico-basal 
axis  into  2  mm  thick  sections.  The  slices  were 
incubated  by  1%  (w/v)  TTC  solution  in  phosphate 
buffer (pH=7.4)  for  15 min  at  37°C to  dye  the  non-
infarcted  region.
36,37  This  procedure  resulted  in  the 
normally  perfused  tissue  being  stained  blue,  non-
infarcted,  non-perfused  tissue  stained  brick  red  and 
infarcted tissue remaining unstained and appeared pale. 
After  fixing  the  slices  in  formalin  10%  (v/v)  for  24 
h,the  infarct  size  was  determined  by  using  a 
computerized planimetty package.
38-40 
 
Statistical analysis 
Except  for  the  incidence  of  VT  and  VF  which  are 
expressed  as  percentage,  all  the  other  results  are 
expressed as Mean±SEM. To compare the number of 
VEBs, single ectopic beats, salvos, VT and duration of 
VT and VF between groups, the Mann-Whitney non-
parametric  U-test  was  employed.  For  analyzing  the 
incidence of VT and VF, Fisher exact test (Chi-square 
with Yates correction) was used. The mean percentage 
of  infarct  size  was  analyzed  using  one-way  ANOVA 
and then significant differences were examined by LSD 
post hoc range test. Differences between groups were 
considered significant at a level of P<0.05. 
 
Results and Discussion 
The  effects  of  administration  of  natural  honey  on 
reperfusion- induced cardiac arrhythmias after 30 min 
zero flow global ischemia are summarized in Table 1. 
As shown in the table 1 and Figure 1, perfusion of K/H 
solution  containing  natural  honey  for  15  min  before 
induction of global ischemia significantly decreased the 
total  number  of  VEBs.  In  the  control  group,  VEBs  
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number was 784±200, while the value was decreased 
by  natural  honey  (0.25,  0.5,  1  and  2%)  to  240±68 
(P<0.01),  277±68  (P<0.05),  242±57  (P<0.05)  and 
173±62 (P<0.01), respectively). The number of single 
ectopic  beats  decreased  by  all  used  honey 
concentrations  of  honey,  however  as  illustrated  in 
Figure 2, the effect was statistically significant only by 
1 and 2 % honey (P<0.01). Natural honey (0.25, 0.5, 1 
and 2%) also markedly lowered the number of salvos 
arrhythmias compared to the control group (P<0.01 for 
all). Number and duration of VT were also reduced by 
natural honey (Table 1 and Figure 2, Figure 3). 
 
Table 1. Effects of administration of natural honey (0.25, 0.5, 1 and 2 %) on reperfusion- induced cardiac arrhythmias after 30 min zero 
flow global ischemia in isolated rat heart. 
** P<0.01, * P<0.05 versus the control group. N=10-14 in each group. VT: Ventricular Tachycardia, VEBs: Ventricular Ectopic Beats 
(Single+Salvos+VT), Rev VF: Reversible Ventricular Fibrillation, Irrev VF: Irreversible Ventricular Fibrillation 
 
 
 
 
 
 
 
 
 
Figure 3. Duration of ventricular tachycardia (VT) in the control 
and treated groups receiving 0.25, 0.5, 1 and 2 % of honey for 
15  minutes  before  induction  of  30  min  zero  flow  global 
ischemia.  Data  are  represented  as  Mean±SEM.  *P<0.05 
versus the control group. N=10-14 in each group. 
 
The time spent in reversible VF was 248±76 sec in the 
control  group  and  different  concentrations  of  honey 
reduced  the  time  not  statistically  significant.  In 
addition, honey significantly lowered the incidence of 
Iirrev  VF  by  0.25,  0.5  and  1  %  concentrations 
(P<0.05), however, the incidences of VT and Rev VF 
did not show significant reduction. Effects of honey on 
the myocardial infarction size are summarized in table 
2. Perfusion of the isolated rat hearts by K/H solution 
containing  natural  honey  for  15  min  before  global 
ischemia  markedly  reduced  infarct  size  by  all  used 
concentration. As shown in  Figure  4, the infarct  size 
was 55.8±7.8% in the control group, while short-term 
pretreatment of the hearts by 0.5, 1 and 2% of honey 
solution produced significant  reduction in  the size  of 
myocardial  infarction  from  the  control  value  to 
30.6±5.5%  (P<0.01),  17.9±5.6%  (P<0.001)  and 
8.7±1.1%  (P<0.001),  respectively.The  effect  was  not 
significant by 0.25%. In addition, similar to infarct size 
results,  natural  honey  significantly  decreased  the 
infracted volume of ischemic hearts in comparison with 
the  control  group  value  (Table  2).  A  direct  linear 
correlation (R
2=0.9948) between honey concentrations 
and reduction of infarct size was observed (Figure 5).  
 
Groups 
Reperfusion arrhythmias 
VEBs 
number 
VT 
number 
VT  
Duration(sec) 
Rev VF 
Duration (sec) 
Rev VF 
Incidence (%) 
Irrev VF 
Incidence (%) 
VT 
Incidence (%) 
Control  784±200  154±55  22±7  248±76  60  40  67 
Honey (0. 25%)  240±68**  34±24*  5±3*  234±99  60  0*  40 
Honey (0. 5%)  277±68**  86±40  12±5  180±63  100  0*  80 
Honey (1%)  242±57*  111±34  14±4  219±53  85  0*  61 
Honey (2%)  173±62**   50±27*   7±3*   205±54  67   17   42  
Figure 1. The total number of ventricular ectopic beats (VEBs: 
Single+Salvos+VT) in the control and treated groups receiving 
0.25, 0.5, 1 and 2 % of honey for 15 minutes before induction 
of 30 min zero flow global ischemia. Data are represented as 
Mean±SEM.  *P<0.05,  **P<0.01  versus  the  control  group. 
N=10-14 in each group. 
 
Figure  2.  Number  of  single,  salvos  and  VT  (Ventricular 
Tachycardia)  arrhythmias  in  the  control  and  treated  groups 
receiving 0.25, 0.5, 1 and 2 % of honey for 15 minutes before 
induction  of  30  min  zero  flow  global  ischemia.  Data  are 
represented  as  Mean±SEM.  *P<0.05,  **P<0.01  versus  the 
control group. N=10-14 in each group. 
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Table 2. Effects of administration of natural honey (0.25, 0.5, 1 
and 2 %) on myocardial infarction size after 30 min zero flow 
global ischemia followed by 120 min reperfusion in isolated rat 
heart. 
Groups  Risk zone 
vol.(mm)³ 
Infarcted 
vol.(mm)³ 
Infarct size (%) 
Control  1278±58  723±113  55.8±7.8 
Honey (0. 25%)  1325±115  592±190  39.3±11.0 
Honey (0. 5%)  1249±39  390±75 **  30.6±5.5** 
Honey (1%)  1152±50  232±91 **  17.9±5.6*** 
Honey (2%)  1148±27  101±13 ***  8.7±1.1*** 
Data  are  represented  as  Mean±SEM.  **P<0.01,  ***P<0.001 
versus the control group. N=10-14 in each group. 
 
 
Figure 4. Myocardial infarction size in the control and treated 
groups receiving 0.25, 0.5, 1 and 2 % of honey for 15 minutes 
before induction of 30 min zero flow global ischemia followed 
by 120 min reperfusion. Data are represented as Mean±SEM. 
**P<0.01,  ***P<0.001  versus  the  control  group.  N=10-14  in 
each group. 
 
 
Figure  5.  Relationship  between  myocardial  infarct  size 
reduction and honey concentrations (0. 25-2%) in isolated rat 
hearts. Data are represented as Mean±SEM. N=10-14 in each 
group.  
Discussion 
Cardiac  arrhythmias  remain  a  major  source  of 
morbidity and mortality in developed countries.
41 In the 
course  of  cardiac  surgery  and  myocardial  infarction, 
ventricular  arrhythmias  such  as  VT  and  VF  are  the 
most important cause of mortality.
42 The results of this 
work showed that honey can protect isolated rat hearts 
against reperfusion- induced cardiac arrhythmias after 
30  min  zero  flow  global  ischemia.  In  this  condition, 
perfusion  of  K/H  solution  containing  natural  honey 
reduced  the  total  number  of  VEBs,  the  number  of 
single ectopic beats and salvos arrhythmias compared 
to the control group. In addition, number and duration 
of  VT  and  incidence  of  Iirrev  VF  were  reduced  by 
some  concentrations  of  natural  honey.  Additionally, 
honey reduced duration and incidence of reversible VF. 
Although  honey  has  been  applied  for  medicinal 
purposes since ancient times,
43 however, as mentioned 
before, there is not enough report on its effects against 
I/R  injuries  in  the  literature.  In  the  case  of 
cardiovascular  diseases,  most  of  the  previous  studies 
are  focused  on  honey's  effects  against  cardiovascular 
risk factors such as hyperlipidemia and production of 
free  radicals.
44-48  The  results  of  a  previous  study  in 
2011  revealed  that  chronic  administration  of  honey 
(feeding of rats by different concentrations of honey for 
45 days) had antiarrhythmic effects.
29 In spite of some 
methodological differences between the present and the 
above  study  (such  as  type  of  ischemia,  experimental 
protocols  and  the  administration  period  of  honey), 
findings  of  both  studies  are  in  consistent  with  them. 
That is, acute short-term or chronic administration of 
honey  protects  isolated  rat  heart  against  I/R-induced 
arrhythmias
29 regardless of ischemia type. Although all 
used  concentration  of  honey  showed  this  protective 
effect,  it  seems  that  0.25%  had  partially  better 
antiarrhythmic effects in this model of study. Probably, 
the  existence  of  high  amount  of  glucose  in  higher 
concentrations of honey may change glucose to lactate 
in  ischemic  condition  then  causes  electrical  and 
contractility disturbances in the heart.
29 In other study, 
pretreatment  of  anesthetized  normal  or  stressed  rats 
with  natural  wild  honey  (5  g/kg)  for  1  h  prior  to 
adrenaline injection (100 mcg/kg) could protect them 
from  epinephrine-induced  vasomotor  dysfunction  and 
cardiac disorders and preserved the positive inotropic 
effect of adrenaline. The authors concluded that natural 
wild  honey  might  cause  its  cardioprotective  effects 
against  adrenaline-induced  cardiac  and  vasomotor 
dysfunction  directly  (via  its  high  total  antioxidant 
capacity and enzymatic and nonenzymatic antioxidants, 
besides  its  substantial  quantities  of  mineral  elements 
and/or indirectly by stimulating release of nitric oxide 
from endothelium through the influence of vitamin C.
6 
Under  conditions  of  I/R  that  weaken  the  cardiac 
antioxidant system and make the tissue overexposed to 
ROS production, the myocardium may be subjected to 
oxidative damage.
49 Probably, the antioxidant activity 
of  honey  and  scavenging  of  free  radicals  that 
demonstrated  in  some  previous  studies  may  play 
important role in the above protective effects of honey 
as well.
19,24,50-53 In general, the antioxidant capacity of 
honey appeared to be a result of the combined activity 
of  a  wide  range  of  compounds  including  phenolics, 
peptides,  organic  acids,  enzymes,  Millard  reaction 
products, and possibly other minor components.
53 As a 
result,  it  may  be  suggested  that  protective  effects  of 
natural  honey  against  I/R-induced  arrhythmias  may 
also be related to its both nonenzymatic (such as GSH  
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and ascorbic acid) and enzymatic antioxidants (such as 
SOD and CAT).
4-6 Moreover, honey is extraordinarily 
rich in minerals, mainly calcium, potassium, chlorine, 
sodium,  iron,  magnesium  and  zinc.
3,6,51  It  seems  that 
some of these minerals may be responsible, in part, for 
the anti-arrhythmic effects of honey. The data linking 
hypokalemia  with  arrhythmia  and  cardiac  arrest  in 
acute  myocardial  infarction  are  fairly  strong.
54 
Hypokalemic  ventricular  ectopy  is  suppressed  by 
potassium replacement.
54 It has been reported that zinc 
has an inhibitory action on the free radical formation in 
the  heart,  since  it  interferes  with  the  processes  that 
initiate  arrhythmias.  Magnesium,  by  inhibiting  the 
voltage-dependent  calcium  channels,  may  prevent 
cardiac arrhythmias. Also, sodium, through the process 
of Na
+/ Ca
2+ exchange, can prevent the increase of Ca
2+ 
ions within the cardiac cells and reduce the incidence 
of  ventricular  arrhythmias.
6  Our  findings  also 
demonstrated that pretreatment of isolated rat hearts by 
natural  honey  caused  significant  and  potent 
cardioprotection against myocardial infarction as one of 
the  most  important  predominant  determinants  of  I/R 
induced  injuries  (figure  2).  Administration  of  honey 
(0.25, 0.5, 1 and 2%) 15 min before zero flow global 
ischemia followed by 120 min reperfusion lowered the 
infarction size 29.5, 45.1 (P<0.01), 67.9 (P<0.001) and 
84.4% (P<0.001), respectively versus the control group 
value (100%). Regarding the used concentration range 
of  honey  in  our  model,  reduction  of  infarct  size  is 
concentration  dependent  and  there  is  a  direct  linear 
relationship (with an equation of y=-10.45x+50.25 and 
r
2=0.9948)  between  honey  concentration  and  its 
protective  effect  (figure  5).  Therefore,  the  higher 
concentrations  of  honey  (particularly  1  and  2%)  are 
more effective than lower concentrations for decreasing 
myocardial  infarction.  Similar  to  antiarrhythmic 
effects,  reduction  of  infarct  size  in  this  work  is  in 
consistence  with  the  findings  of  previous  study.
29 
However,  the  exact  cardioprotective  mechanisms  of 
natural honey in reducing infarct size are not clear yet. 
Regarding the antioxidant and free radical scavenging 
activity  of  natural  honey,
7,19,53  we  proposed  that  the 
above properties may be responsible, in part, for infarct 
size  reduction  in  ischemic  reperfused  heart.  Other 
potential  mechanisms  to  decrease  myocardial  infarct 
size  by  honey  may  include  anti-inflammatory 
effects,
12,20,22  decrease  in  the  measurement  of 
necrotized  tissue
21,22  and  antiarrhythmic  effects.
29 
Perhaps,  antioxidant  activity,  scavenging  of  free 
radicals  and  the  existence  of  high  energy  sources  in 
honey composition (such as fructose and glucose) may 
be  the  most  important  potential  cardioprotective 
mechanisms of honey.  
Conclusion 
By  considering  the  data,  it  may  be  concluded  that 
preischemic  administration  of  natural  honey  before 
zero  flow  global  ischemia  followed  by  120  min 
reperfusion  can  protect  isolated  rat  hearts  and 
consequently has antiarrhythmic activity and reducing 
infarction  size.Antioxidant  and  radical  scavenging 
activity,  presence  of  rich  energy  sources,  many 
vitamins, minerals and enzymes may probably involve 
in the cardioprotective effects of natural honey in such 
conditions. Future studies are required to determine the 
exact protective mechanism (s) of honey. 
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